The Lancet
-
In preparation for future transplants
Lessons learned from world’s first successful transplant of genetically-modified pig heart into human patient. Deborah Kotz, from University of Maryland…
Read More » -
COVID-19 vaccine efficacy does not support boosters for general population: Expert review
The review, published in The Lancet, summarises the currently available evidence from randomised controlled trials and observational studies published in peer-reviewed journals …
Read More » -
Long-lasting symptoms from COVID-19 are rare in children: UK study
The study is published in The Lancet Child & Adolescent Health journal Children who develop symptoms of COVID-19 typically get better after…
Read More » -
Experts call for urgent action to improve physical activity worldwide: The Lancet
Physical inactivity is linked to an increased risk of non-communicable diseases (NCDs) such as heart disease, diabetes and some cancers…
Read More » -
Cytel calls for statistical innovation for global health challenges
Cytel and its collaborators have analysed the challenges of conducting high-quality clinical research in LMICs – a critical barrier to…
Read More » -
More nurses lead to fewer patient deaths, readmissions: Australian study
The study of more than 400,000 patients and 17,000 nurses in 27 hospitals that implemented the policy and 28 comparison…
Read More » -
COVID-19 repeat infections rare, but more common for above age 65: The Lancet study
People over the age of 65 are at greater risk of catching COVID-19 again, with only 47 per cent protection…
Read More » -
The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine launched
The commission aims to provide data and guidance to catalyse sustainable improvement of medical imaging and nuclear medicine services for…
Read More » -
Arthritis drug Tocilizumab reduces deaths in severe COVID-19: Study
Eleven public and private tertiary care hospitals from 10 Indian cities participated in the study India’s first multicentre randomised controlled…
Read More » -
Three-month interval between doses of Oxford COVID-19 vaccine results in higher efficacy: The Lancet
The study also includes updated estimates of overall vaccine efficacy against symptomatic disease for two standard doses, which confirm that…
Read More »
